BlinkLab Limited (ASX:BB1)
Australia · Delayed Price · Currency is AUD 0.9050
+0.0900 (11.04%)
Aug 20, 2026, 4:10 PM AEST
BlinkLab Revenue
In the fiscal year ending June 30, 2026, BlinkLab had annual revenue of 1.21M AUD with 221.54% growth. BlinkLab had revenue of 1.05M in the half year ending June 30, 2026, with 2,931.23% growth.
Revenue
1.21M
Revenue Growth
+221.54%
P/S Ratio
103.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
124.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.21M | 832.01K | 221.54% |
| Jun 30, 2025 | 375.55K | 338.59K | 916.07% |
| Jun 30, 2024 | 36.96K | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 87.98M |
| Doctor Care Anywhere Group | 75.18M |
| Alcidion Group | 51.64M |
| Mach7 Technologies | 29.70M |
| Beamtree Holdings | 28.90M |
| Oneview Healthcare | 21.12M |
| PharmX Technologies | 7.65M |
| Vitasora Health | 5.01M |